LeMaitre Vascular, Inc. (LMAT) Financials
LMAT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 346.8 million | 48.9 million |
2023-09-30 | 334.0 million | 45.4 million |
2023-06-30 | 326.5 million | 42.6 million |
2023-03-31 | 314.9 million | 40.7 million |
LMAT Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 9.5 million | 1.4 million |
2023-09-30 | 10.8 million | 1.3 million |
2023-06-30 | 9.1 million | 1.3 million |
2023-03-31 | 149000 | 1.3 million |
LMAT Net Income
Date | Net Income |
---|---|
2023-12-31 | 8.5 million |
2023-09-30 | 7.5 million |
2023-06-30 | 8.1 million |
2023-03-31 | 6.0 million |
LMAT Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 105.1 million | - | 19.1 million |
2023-09-30 | 97.0 million | - | 16.9 million |
2023-06-30 | 90.2 million | - | 16.8 million |
2023-03-31 | 81.0 million | - | 16.5 million |
LMAT Shares Outstanding
LMAT Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.3 million | 4.4 million | 8.4 million | 10.3 million |
2023-09-30 | 1.1 million | 4.2 million | 7.7 million | 9.7 million |
2023-06-30 | 2.8 million | 4.5 million | 7.7 million | 10.2 million |
2023-03-31 | 2.1 million | 3.9 million | 7.9 million | 10.9 million |
LMAT Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 48.9 million | 17.1 million |
2023-09-30 | 47.4 million | 16.6 million |
2023-06-30 | 50.1 million | 18.0 million |
2023-03-31 | 47.1 million | 16.2 million |
LMAT
List: Contenders
Price: $64.03
Dividend Yield: 0.01%
Forward Dividend Yield: 1.00%
Payout Ratio: 52.46%
Dividend Per Share: 0.64 USD
Earnings Per Share: 1.34 USD
P/E Ratio: 50.39
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 56800
Ebitda: 6.1 millionMarket Capitalization: 1.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 12.12%
DGR5: 14.37%
DGR10: 14.46%